Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02653729Phase 2Completed
Phase 2, randomised, single-blind trial in psychosis. Primary endpoints: Positive and Negative Symptom Scale at 12 weeks and Schedule for Assessment of Insight at 12 weeks. Started Sep 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02653729.